Top

Published in:

01-12-2023 | Obesity | Original Article

Prevalence of osteosarcopenic obesity and related factors among Iranian older people: Bushehr Elderly Health (BEH) program

Authors: Mozhgan Ahmadinezhad, Mohammad Ali Mansournia, Noushin Fahimfar, Gita Shafiee, Iraj Nabipour, Mahnaz Sanjari, Kazem Khalagi, Mohammad Javad Mansourzadeh, Bagher Larijani, Afshin Ostovar

Published in: Archives of Osteoporosis | Issue 1/2023

Abstract

Summary

Osteosarcopenic obesity is a new syndrome that has been recently discussed in the scientific community. It is a condition that affects the elderly and involves the loss of bone, muscle, and fat tissue. The few studies that have been done on this disease showed that it has a high prevalence among the elderly and can cause various complications. This study was the first one to investigate this syndrome in Iran, and found that its prevalence was 19.83%.

Background

Osteosarcopenic obesity syndrome (OSO) is a condition that involves osteopenia/osteoporosis, sarcopenia, and obesity. It leads to a reduction in the quality of life of the elderly and an increase in hospitalization which has attracted the attention of physicians. This study aimed to determine the prevalence and risk factors of osteosarcopenic obesity in people over 60 years of age in Bushehr.

Materials and methods

We used data from the Bushehr study, which included 2426 participants aged ≥ 60 years. We assessed osteoporosis/osteopenia based on T-score; sarcopenia based on hand grip strength, skeletal muscle mass index (SMI), and walking speed; and obesity based on fat mass and BMI for diagnosing OSO. We first examined the factors related to OSO in the univariable analysis and then fitted the multiple logistic regression model, separately for women and men. The result was summarized as adjusted odds ratios with a 95% confidence interval.

Results

In total, 2339 elderly were examined in our study, of which 464 elderly were suffering from osteosarcopenic obesity. The standardized prevalence of OSO was 23.66% (95% CI: 21.15–26.16) in women and 18.53% (95% CI 16.35–20.87) in men. Age was positively linked to osteosarcopenic obesity in both genders and so was diabetes in men. However, education, physical activity, and protein intake were negatively linked to osteosarcopenic obesity in both genders, as well as hypertriglyceridemia and hypertension in women.

Conclusion

The prevalence of OSO among men and women of Bushehr city is high and is related to increasing age, low levels of education, physical activity, and protein intake among women and men.

Olshansky SJ, Goldman DP, Zheng Y, Rowe JW (2009) Aging in America in the twenty-first century: demographic forecasts from the MacArthur foundation research network on an aging society. Milbank Q 87(4):842–862PubMedPubMedCentral

Jaul E, Barron J (2017) Age-related diseases and clinical and public health implications for the 85 years old and over population. Front Public Health 5:335PubMedPubMedCentral

Coughlan T, Dockery F (2014) Osteoporosis and fracture risk in older people. Clin Med (Lond) 14(2):187–191PubMed

Dodds RM, Roberts HC, Cooper C, Sayer AA (2015) The epidemiology of sarcopenia. J Clin Densitom: Off J Int Soc Clin Densitom 18(4):461–466

Jura M, Kozak LP (2016) Obesity and related consequences to ageing. Age (Dordr) 38(1):23PubMed

Reyes-Farias M, Fos-Domenech J, Serra D, Herrero L, Sánchez-Infantes D (2021) White adipose tissue dysfunction in obesity and aging. Biochem Pharmacol 192:114723PubMed

Zhao LJ, Jiang H, Papasian CJ, Maulik D, Drees B, Hamilton J et al (2008) Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosis. J Bone Miner Res: Off J Am Soc Bone Miner Res 23(1):17–29

Ilich JZ, Kelly OJ, Inglis JE (2016) Osteosarcopenic obesity syndrome: what is it and how can it be identified and diagnosed? Curr Gerontol Geriatr Res 2016:7325973PubMedPubMedCentral

Keramidaki K, Tsagari A, Hiona M, Risvas G (2019) Osteosarcopenic obesity, the coexistence of osteoporosis, sarcopenia and obesity and consequences in the quality of life in older adults ≥65 years-old in Greece. J Frailty, Sarcopenia Falls 4(4):91–101PubMed

10.

Ma Y, Zhang W, Han P, Kohzuki M, Guo Q (2020) Osteosarcopenic obesity associated with poor physical performance in the elderly Chinese community. Clin Interv Aging 15:1343–1352PubMedPubMedCentral

11.

Kolbaşı EN, Demirdağ F (2020) Prevalence of osteosarcopenic obesity in community-dwelling older adults: a cross-sectional retrospective study. Arch Osteoporos 15(1):166PubMed

12.

Szlejf C, Parra-Rodríguez L, Rosas-Carrasco O (2017) Osteosarcopenic obesity: prevalence and relation with frailty and physical performance in middle-aged and older women. J Am Med Dir Assoc 18(8):733.e1-e5PubMed

13.

Lee K (2020) Association of osteosarcopenic obesity and its components: osteoporosis, sarcopenia and obesity with insulin resistance. J Bone Miner Metab 38(5):695–701PubMed

14.

Chen X, Kong C, Yu H, Gong J, Lan L, Zhou L et al (2019) Association between osteosarcopenic obesity and hypertension among four minority populations in China: a cross-sectional study. BMJ Open 9(7):e026818PubMedPubMedCentral

15.

Mo D, Hsieh P, Yu H, Zhou L, Gong J, Xu L et al (2018) Osteosarcopenic obesity and its relationship with dyslipidemia in women from different ethnic groups of China. Arch Osteoporos 13(1):65PubMed

16.

Choi MK, Bae YJ (2020) Protein intake and osteosarcopenic adiposity in Korean adults aged 50 years and older. Osteoporos Int: J Established Result Cooperation Between Eur Found Osteoporos Natl Osteoporos Found USA 31(12):2363–2372

17.

Dos Santos VR, Gobbo LA (2020) Physical activity is associated with functional capacity of older women with osteosarcopenic obesity: 24-month prospective study. Eur J Clin Nutr 74(6):912–919PubMed

18.

Shafiee G, Ostovar A, Heshmat R, Darabi H, Sharifi F, Raeisi A et al (2017) Bushehr Elderly Health (BEH) programme: study protocol and design of musculoskeletal system and cognitive function (stage II). BMJ Open 7(8):e013606PubMedPubMedCentral

19.

Aadahl M, Jørgensen T (2003) Validation of a new self-report instrument for measuring physical activity. Med Sci Sports Exerc 35(7):1196–1202PubMed

20.

Rothney MP, Brychta RJ, Schaefer EV, Chen KY, Skarulis MC (2009) Body composition measured by dual-energy X-ray absorptiometry half-body scans in obese adults. Obesity (Silver Spring, Md) 17(6):1281–1286PubMed

21.

Sheu A, Diamond T (2016) Bone mineral density: testing for osteoporosis. Aust Prescr 39(2):35–39PubMedPubMedCentral

22.

Jang HN, Moon MK, Koo BK (2022) Prevalence of diabetic retinopathy in undiagnosed diabetic patients: a nationwide population-based study. Diabetes Metab J 46(4):620–629PubMedPubMedCentral

23.

Shafiee G, Ostovar A, Heshmat R, Keshtkar AA, Sharifi F, Shadman Z et al (2018) Appendicular skeletal muscle mass reference values and the peak muscle mass to identify sarcopenia among Iranian healthy population. Int J Prev Med 9:25PubMedPubMedCentral

24.

Li Y, Wang H, Wang K, Wang W, Dong F, Qian Y et al (2017) Optimal body fat percentage cut-off values for identifying cardiovascular risk factors in Mongolian and Han adults: a population-based cross-sectional study in Inner Mongolia, China. BMJ Open 7(4):e014675PubMedPubMedCentral

25.

Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart. Lung, and Blood Institute scientific statement. 112(17):2735–52

26.

Brooks GA, Butte NF, Rand WM, Flatt JP, Caballero B (2004) Chronicle of the Institute of Medicine physical activity recommendation: how a physical activity recommendation came to be among dietary recommendations. Am J Clin Nutr 79(5):921s-s930PubMed

27.

Mahan LK, Raymond JL (2016) Krause and Mahan’s food and the nutrition are process-e-book, 15th edn. Elsevier Health Sciences

28.

Mansournia MA, Collins GS, Nielsen RO, Nazemipour M, Jewell NP, Altman DG et al (2021) A CHecklist for statistical Assessment of Medical Papers (the CHAMP statement): explanation and elaboration. Br J Sports Med 55(18):1009–1017PubMed

29.

Mansournia MA, Collins GS, Nielsen RO, Nazemipour M, Jewell NP, Altman DG et al (2021) CHecklist for statistical Assessment of Medical Papers: the CHAMP statement. Br J Sports Med 55(18):1002–1003PubMed

30.

Greenland S, Mansournia MA, Joffe M (2022) To curb research misreporting, replace significance and confidence by compatibility: a preventive medicine golden jubilee article. Prev Med 164:107127PubMed

31.

Mansournia MA, Nazemipour M, Etminan M (2022) P-value, compatibility, and S-value. Glob Epidemiol 4:100085PubMedPubMedCentral

32.

Etminan M, Brophy JM, Collins G, Nazemipour M, Mansournia MA (2021) To adjust or not to adjust: the role of different covariates in cardiovascular observational studies. Am Heart J 237:62–67. https://doi.org/10.1016/j.ahj.2021.03.008CrossRefPubMed

33.

Chung JH, Hwang HJ, Shin HY, Han CH (2016) Association between sarcopenic obesity and bone mineral density in middle-aged and elderly Korean. Ann Nutr Metab 68(2):77–84PubMed

34.

Kim J, Lee Y, Kye S, Chung YS, Kim JH, Chon D et al (2017) Diet quality and osteosarcopenic obesity in community-dwelling adults 50 years and older. Maturitas 104:73–79PubMed

35.

Cunha PM, Ribeiro AS, Tomeleri CM, Schoenfeld BJ, Silva AM, Souza MF et al (2018) The effects of resistance training volume on osteosarcopenic obesity in older women. J Sports Sci 36(14):1564–1571PubMed

36.

Lee SH, Lee JY, Lim KH, Lee YS, Koh JM (2022) Associations between plasma growth and differentiation factor-15 with aging phenotypes in muscle, adipose tissue, and bone. Calcif Tissue Int 110(2):236–243PubMed

37.

Kim J, Lee Y, Kye S, Chung YS, Lee O (2017) Association of serum vitamin D with osteosarcopenic obesity: Korea National Health and Nutrition Examination Survey 2008–2010. J Cachex Sarcopenia Muscle 8(2):259–266

38.

Kelly OJ, Gilman JC, Kim Y, Ilich JZ (2017) Macronutrient intake and distribution in the etiology, prevention and treatment of osteosarcopenic obesity. Curr Aging Sci 10(2):83–105PubMed

39.

Lin CL, Lee MC, Hsu YJ, Huang WC, Huang CC, Huang SW (2018) Isolated soy protein supplementation and exercise improve fatigue-related biomarker levels and bone strength in ovariectomized mice. Nutrients 10(11):1792PubMedPubMedCentral

40.

Hita-Contreras F, Martínez-Amat A, Cruz-Díaz D, Pérez-López FR (2015) Osteosarcopenic obesity and fall prevention strategies. Maturitas 80(2):126–132PubMed

41.

Wang T, Feng X, Zhou J, Gong H, Xia S, Wei Q et al (2016) Type 2 diabetes mellitus is associated with increased risks of sarcopenia and pre-sarcopenia in Chinese elderly. Sci Rep 6:38937PubMedPubMedCentral

42.

Janghorbani M, Van Dam RM, Willett WC, Hu FB (2007) Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol 166(5):495–505PubMed

43.

Grant B, Sandelson M, Agyemang-Prempeh B, Zalin A (2021) Managing obesity in people with type 2 diabetes. Clin Med (Lond) 21(4):e327–e231PubMed

44.

Endo T, Akai K, Kijima T, Kitahara S, Abe T, Takeda M et al (2021) An association analysis between hypertension, dementia, and depression and the phases of pre-sarcopenia to sarcopenia: a cross-sectional analysis. PLoS One 16(7):e0252784PubMedPubMedCentral

45.

Wu HL, Yang J, Wei YC, Wang JY, Jia YY, Li L et al (2022) Analysis of the prevalence, risk factors, and clinical characteristics of osteoporosis in patients with essential hypertension. BMC Endocr Disord 22(1):165PubMedPubMedCentral

46.

Hu Z, Yang K, Hu Z, Li M, Wei H, Tang Z et al (2021) Determining the association between hypertension and bone metabolism markers in osteoporotic patients. Medicine (Baltimore) 100(24):e26276PubMed

Title: Prevalence of osteosarcopenic obesity and related factors among Iranian older people: Bushehr Elderly Health (BEH) program
Authors: Mozhgan Ahmadinezhad
Mohammad Ali Mansournia
Noushin Fahimfar
Gita Shafiee
Iraj Nabipour
Mahnaz Sanjari
Kazem Khalagi
Mohammad Javad Mansourzadeh
Bagher Larijani
Afshin Ostovar
Publication date: 01-12-2023
Publisher: Springer London
Keywords: Obesity
Obesity
Sarcopenia
Osteoporosis
Osteoporosis
Hypertension
Hypertension
Published in: Archives of Osteoporosis / Issue 1/2023
Print ISSN: 1862-3522
Electronic ISSN: 1862-3514
DOI: https://doi.org/10.1007/s11657-023-01340-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Prevalence of osteosarcopenic obesity and related factors among Iranian older people: Bushehr Elderly Health (BEH) program

Abstract

Summary

Background

Materials and methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Summary

Background

Materials and methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2023

The effect of patient positioning on measurements of bone mineral density of the proximal femur: a simulation study using computed tomographic images

First Ecuadorian statement consensus for the evaluation and treatment of osteoporosis

The association between weather warnings and hip fractures in the Republic of Ireland

Spinal medial branch nerve root block (MBNB) intervention compared to standard care-vertebroplasty (VP) for the treatment of painful osteoporotic vertebral fractures in frail, older hospitalised patients: a feasibility study

Trabecular bone score (TBS) and bone mineral density (BMD) analysis by dual X‐ray absorptiometry (DXA) in healthy Brazilian children and adolescents: normative data

Reducing the risk of denosumab-induced hypocalcemia in patients with advanced chronic kidney disease: a quality improvement initiative